Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation

Completed · Phase 2/Phase 3

Conditions studied: Ejaculation

In brief

Assessment of efficacy and safety UK-390,957

Key facts

Study ID
NCT00219635
Run by
Pfizer
People needed
138
Starts
2005-01-01
Expected to finish
2005-07-01
Last updated by the study team
2012-11-07

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.